Page last updated: 2024-08-21

antimycin a and Bladder Cancer

antimycin a has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Huang, K; Lan, L; Liu, Y; Lu, B; Shi, Y; Wang, L; Wang, R; Wu, X; Wu, Z; Xu, C; Yu, X; Zhang, J; Zhu, H	1

Other Studies

1 other study(ies) available for antimycin a and Bladder Cancer

Article	Year
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer. Oncotarget, 2014, Nov-30, Volume: 5, Issue:22 Topics: Aged; Antimycin A; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Energy Metabolism; Female; Gene Knockdown Techniques; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitochondria; Molecular Targeted Therapy; Protease Inhibitors; Protease La; Reactive Oxygen Species; RNA, Messenger; Urinary Bladder Neoplasms	2014

Article

Year

Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer.

Oncotarget, 2014, Nov-30, Volume: 5, Issue:22

Topics: Aged; Antimycin A; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Energy Metabolism; Female; Gene Knockdown Techniques; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitochondria; Molecular Targeted Therapy; Protease Inhibitors; Protease La; Reactive Oxygen Species; RNA, Messenger; Urinary Bladder Neoplasms

2014